Sept. 14, 2012
-- Blackpool, UK – 14 September 2012 – CME Medical, the UK’s fastest growing specialist infusion company, has today launched new marketing literature for its extensive portfolio of pain management pumps, including the BodyGuard range.
There is literature for the 595TM Regional Analgesia Infusion Pump for nerve block and wound infiltration;
the 575TM Pain Management Infusion Pump for Patient Controlled Analgesia (PCA), the 545TM Epidural Infusion Pump, the 323TM Ambulatory Infusion Pump and the 2CHTM Twin Channel Infusion Pump, both suitable for Total Parenteral Nutrition (TPN) and general infusion.
The literature, which can be downloaded from CME Medical’s website, highlight the benefits to clinicians and their patients of using CME Medical’s safety enhanced dedicated infusion devices, including digital descriptive displays, safety software built in as standard and a full programme of training, clinical support and technical support. They also feature key product technical specifications and accessories.
The series includes brand new literature for the T34™ Ambulatory Syringe Pump and a Supporting Information document - essential reading for anyone formulating a Purchasing for Safety Initiative for safer ambulatory syringe drivers to meet the requirements of the NPSA Rapid Response Report. It highlights ways CME Medical can help with a safe and successful transition, including training workshops and ways to reduce risk.
For more information, please visit the CME Medical website at www.cmemedical.co.uk or link to this release.